Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are expecting strong performance driven by the continued success of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential challenges